These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Current concepts in the diagnosis and management of left ventricular assist device infections. Nienaber J; Wilhelm MP; Sohail MR Expert Rev Anti Infect Ther; 2013 Feb; 11(2):201-10. PubMed ID: 23409825 [TBL] [Abstract][Full Text] [Related]
9. Outcomes associated with surgical management of infections related to the HeartMate II left ventricular assist device: Implications for destination therapy patients. Chamogeorgakis T; Koval CE; Smedira NG; Starling RC; Gonzalez-Stawinski GV J Heart Lung Transplant; 2012 Aug; 31(8):904-6. PubMed ID: 22759802 [No Abstract] [Full Text] [Related]
10. An infection with linezolid-resistant S. aureus in a patient with left ventricular assist system. Kola A; Kirschner P; Gohrbandt B; Chaberny IF; Mattner F; Strüber M; Gastmeier P; Suerbaum S Scand J Infect Dis; 2007; 39(5):463-5. PubMed ID: 17464873 [TBL] [Abstract][Full Text] [Related]
11. Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients. Papathanasiou M; Pohl J; Jánosi RA; Pizanis N; Kamler M; Rassaf T; Luedike P Ann Thorac Surg; 2018 Feb; 105(2):557-563. PubMed ID: 29174784 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of combination of N-acetylcysteine, gentamicin, and amphotericin B for prevention of microbial colonization of ventricular assist devices. Hernandez MD; Mansouri MD; Aslam S; Zeluff B; Darouiche RO Infect Control Hosp Epidemiol; 2009 Feb; 30(2):190-2. PubMed ID: 19090771 [TBL] [Abstract][Full Text] [Related]
13. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices. Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literature. Levy DT; Steed ME; Rybak MJ; Guo Y; Gialanella P; Hanau L; Muggia V; Ostrowsky B Transpl Infect Dis; 2012 Oct; 14(5):E89-96. PubMed ID: 22931050 [TBL] [Abstract][Full Text] [Related]
16. Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant. Peghin M; Maiani M; Castaldo N; Givone F; Righi E; Lechiancole A; Sartor A; Pea F; Livi U; Bassetti M Infection; 2018 Apr; 46(2):263-265. PubMed ID: 29086895 [TBL] [Abstract][Full Text] [Related]
17. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. Hannan MM; Husain S; Mattner F; Danziger-Isakov L; Drew RJ; Corey GR; Schueler S; Holman WL; Lawler LP; Gordon SM; Mahon NG; Herre JM; Gould K; Montoya JG; Padera RF; Kormos RL; Conte JV; Mooney ML; J Heart Lung Transplant; 2011 Apr; 30(4):375-84. PubMed ID: 21419995 [No Abstract] [Full Text] [Related]
18. Infection in ventricular assist devices: the role of biofilm. Padera RF Cardiovasc Pathol; 2006; 15(5):264-270. PubMed ID: 16979033 [TBL] [Abstract][Full Text] [Related]
19. [Avoidance and therapy of post-operative infections]. Maier S; Kramer A; Heidecke CD Laryngorhinootologie; 2012 Jan; 91(1):40-59; quiz 60-1. PubMed ID: 22231967 [No Abstract] [Full Text] [Related]
20. [Antibiotic therapy and prophylaxis in liver cirrhosis and infection]. Appenrodt B; Sauerbruch T Dtsch Med Wochenschr; 2007 Mar; 132(12):623-6. PubMed ID: 17357907 [No Abstract] [Full Text] [Related] [Next] [New Search]